4//SEC Filing
Vairavan Latha 4
Accession 0002065881-25-000035
CIK 0001787306other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 6:24 PM ET
Size
5.5 KB
Accession
0002065881-25-000035
Insider Transaction Report
Form 4
Vairavan Latha
SVP Chief Financial Officer
Transactions
- Sale
Common Stock
2025-11-03$24.72/sh−88$2,175→ 64,927 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.435 to $25.31, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0002065881
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 6:24 PM ET
- Size
- 5.5 KB